CDSCO approves Wockhardt’s new generation oral antibiotic Miqnaf (Nafithromycin) EP News Bureau Jan 3, 2025 Miqnaf is an ultra-short course, once-a-day, 3-day treatment for community-acquired bacterial pneumonia (CABP) including those…
